ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

NAMS NewAmsterdam Pharma Company NV

19.19
-0.25 (-1.29%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End
EUR (€)
Total Assets
Total Current Assets
Cash and Equivalents
Total Non-Current Assets
Total Liabilities
Total Current Liabilities
Total Non-Current Liabilities
Common Equity
Retained Earnings
Year End December 30 2023 2023
EUR (€)
Total Assets 347.1M
Total Current Assets 346.79M
Cash and Equivalents 340.45M
Total Non-Current Assets 288.39M
Total Liabilities 58.7M
Total Current Liabilities 49.9M
Total Non-Current Liabilities 8.81M
Total Equity 288.39M
Common Equity 10.17M
Retained Earnings -316.97M

Your Recent History

Delayed Upgrade Clock